Log in to save to my catalogue

Radiolabeling and biological evaluation of 125I-Necitumumab for EGFR-targeted SPECT imaging

Radiolabeling and biological evaluation of 125I-Necitumumab for EGFR-targeted SPECT imaging

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2333963201

Radiolabeling and biological evaluation of 125I-Necitumumab for EGFR-targeted SPECT imaging

About this item

Full title

Radiolabeling and biological evaluation of 125I-Necitumumab for EGFR-targeted SPECT imaging

Publisher

Cham: Springer International Publishing

Journal title

Journal of radioanalytical and nuclear chemistry, 2020-01, Vol.323 (1), p.83-89

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Radiolabeled epidermal growth factor receptor (EGFR) targeted antibody could be used for imaging EGFR expressing cancer. In this study, the SPECT probe
125
I-Necitumumab were synthesized and evaluated for SPECT imaging of non-small cell lung cancer (NSCLC). In vivo biodistribution study indicated that
125
I-Necitumumab was cleared rapid...

Alternative Titles

Full title

Radiolabeling and biological evaluation of 125I-Necitumumab for EGFR-targeted SPECT imaging

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2333963201

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2333963201

Other Identifiers

ISSN

0236-5731

E-ISSN

1588-2780

DOI

10.1007/s10967-019-06933-8

How to access this item